🔎 Trials Near Me

Akèy › Kolit Ulseratif › Distrik Columbia › Washington

Etid klinik pou Kolit Ulseratif nan Washington, DC

12 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Immune Regulation in Ulcerative Colitis or Crohn s Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
1 Day – 75 Years · Tout sèks · Mizajou Oct 5, 2026 · NCT00001184

Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 85 · Tout sèks · Mizajou Oct 5, 2026 · NCT07619547

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1
  • MedStar Georgetown University Hospital, Washington D.C.
  • National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT03816345

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Ap rekriteFaz 4
  • Capital Digestive Care, Chevy Chase · 8 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Sep 30, 2026 · NCT06581328

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • Chevy Chase Clinical Research, Chevy Chase · 8 mi lwen
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07196748

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Ap rekriteFaz 3
  • Capital Digestive Care - Chevy Chase, Chevy Chase · 8 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937086

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Ap rekriteFaz 4
  • Capital Digestive Care - MGG Group - Chevy Chase Clinical Research, Chevy Chase · 8 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06095128

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • Mid-Atlantic GI Research, LLC - Site Number: 8400106, Greenbelt · 11 mi lwen
Laj 16 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Ap rekrite
  • MedStar Georgetown University Hospital, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT05230173

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Ap rekriteEtid obsèvasyon
  • MGG Group Co., Inc., Chevy Chase Clinical Research, Chevy Chase · 8 mi lwen
Laj 18 a 64 · Tout sèks · Mizajou Jul 9, 2026 · NCT06398626

Therapeutic Endpoint in Pediatric IBD Conditions

Ap rekriteEtid obsèvasyon
  • Children's National Health System, Washington D.C.
Laj 6 a 21 · Tout sèks · Mizajou Apr 8, 2026 · NCT06065228

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

Ap rekriteEtid obsèvasyon
  • Capital Digestive Care, Chevy Chase · 8 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 8, 2025 · NCT06750731

Etid Kolit Ulseratif nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.